Horizon Therapeutics
NEWS
Horizon Therapeutics was acquired by Amgen in 2023.
It was another busy week for clinical trial news. Here’s a look.
Biopharma and life sciences organizations from across the globe provide updates on their pipelines and businesses.
Yet another busy week for clinical trial news. Here’s a look.
Biopharma and life sciences companies from across the globe provide updates on their business and pipelines.
Jose Luis Casero Sanchez took advantage of his position in Goldman Sachs’ “control room” to gain insider knowledge of upcoming transactions, including those for several biopharma companies.
Horizon was adding five new development programs for daxdilimab and dazodalibep. This brings the company’s pipeline to 27 development programs.
It was a very busy week for clinical trial announcements, although there were only three that were COVID-19-related. Here’s a look.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Arrowhead will conduct its activities through preclinical development stages, while Horizon will have sole responsibility for the clinical development and commercialization of the medicine.
IN THE PRESS